Dimethyl 2,6-naphthalenedicarboxylate was studied for oral toxicity in rats in a single dose toxicity test at doses of 0, 500, 1000 and 2000 mg/kg. An LD50 value of more than 2000 mg/kg was found for both sexes.
Dimethyl 2,6-naphthalenedicarboxylate was studied for oral toxicity in rats in an OECD combined repeat dose and reproductive/developmental toxicity screening test at doses of 0, 30, 100, 300 and 1000 mg/kg/day. With regard to repeat dose toxicity, no effects of the test substance on males or females were noted. The NOEL for repeat dose toxicity is considered to be 1000 mg/kg/day for both sexes. With regard to reproductive/developmental toxicity, no effects of the test substance on copulation, fertility, delivery as lactation were noted. The NOELs for reproductive performance of males and females, and for pup development are considered to be 1000 mg/kg/day both.
Dimethyl 2,6-naphthalenedicarboxylate was not mutagenic in Salmonella typhimurium TA100, TA1535, TA98, TA1537 and Escherichia coli WP2 uvrA, with or without an exogeneous metabolic activation system.
Genotoxicity of dimethyl 2,6-naphthalenedicarboxylate was studied by chromosomal aberration test in cultured Chinese hamster lung (CHL/IU) cells. Structural chromosomal aberrations were not induced up to a maximum concentration of 2.4 mg/ml (10 mM) with continuous treatment, or by short-term treatment with and without an exogenous metabolic activation system. Polyploidy was induced by continuous treatment with 2.4 mg/ml for 48 h. However, we concluded that dimethyl 2,6-naphthalenedicarboxylate did not induced chromosomal aberrations or polyploidy since the frequency was low.
Purity | : | 99.9% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | OECD Test Guideline 401 |
Route | : | Oral (gavage) |
Doses | : | 0 (vehicle), 500, 1000, 2000 mg/kg/day |
Number of animals/goup | : | Males, 5; females, 5 |
Vehicle | : | 0.5% sodium carboxymethylcelullose solution |
GLP | : | Yes |
Test results:
Purity | : | 99.9% |
Test species/strain | : | Rat/Crj:CD (SD) |
Test method | : | OECD Combined Repeat Dose and Reproductive/Developmental Toxicity Screening Test |
Route | : | Oral (gavage) |
Doses | : | 0 (vehicle), 30, 100, 300, 1000 mg/kg/day |
Number of animals/group | : | Males, 12; females, 12 |
Vehicle | : | 0.5% sodium carboxymethylcellulose solution |
Administration period | : | Males, 49 days Females, from 14 days before mating to day 3 of lactation |
Terminal kill | : | Males, day 50 Females, day 4 of lactation |
GLP | : | Yes |
Purity | : | 99.9 wt% |
Test species/strains | : | Salmonella typhimurium, TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD Guideline No. 471 and 472 |
Procedures | : | Pre-incubation method |
Solvent | : | Water |
Positive controls | : | -S9 mix, 2-(2-Furyl)-3-(5-nitro-2-furyl) acrylamide (TA100, TA98, WP2), Sodium azide (TA1535) and 9-Aminoacridine (TA1537) +S9 mix, 2-Aminoanthracene (five strains) |
Doses | : | -S9 mix; 0, 313, 625, 1250, 2500, 5000 μg/plate (five strains) +S9 mix; 0, 313 - 5000 μg/plate (five strains) |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
Test results:
Genetic effects:
Salmonella typhimurium TA100, TA1535, TA98, TA1537
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] |
Escherichia coli WP2 uvrA
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] |
Purity | : | 99.9 wt% |
Type of cell used | : | Chinese hamster lung (CHL/IU) cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) and OECD Guideline No. 473 |
Vehicle | : | 0.5 % carboxymethylcellulose sodium |
Positive controls | : | -S9 mix, Mitomycin C +S9 mix, Cyclophosphamide |
Doses | : | -S9 mix (continuous treatment):0, 0.60, 1.2, 2.4 mg/ml -S9 mix (short-term treatment):0, 0.60, 1.2, 2.4 mg/ml +S9 mix (short-term treatment):0, 0.60, 1.2, 2.4 mg/ml |
S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
Genotoxic effects:
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
1) | The test was performed by Nihon Bioresearch Inc. Hashima Laboratory, 6-104 Majima, Fukuju-cho, Hashima, Gifu, 501-62 Japan Tel +81-58-392-6222 Fax +81-58-391-3171 |
2) | The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627 |